REPLIGEN CORP Interest Receivable
REPLIGEN CORP (RGEN) had Interest Receivable of $29.00 thousand as of 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Balance Sheet › Assets
us-gaap:InterestReceivable · last filed 2017-02-23
- 2016-12-31: Interest Receivable $29.00K.
- 2015-12-31: Interest Receivable $63.00K.
- 2014-12-31: Interest Receivable $100.00K; Interest Receivable as first filed $99.80K.
- 2013-12-31: Interest Receivable $214.90K.
| Period end | Interest Receivable | Interest Receivable as first filed |
|---|---|---|
| 2016-12-31 | $29.00K 10-K · filed 2017-02-23 | |
| 2015-12-31 | $63.00K 10-K · filed 2017-02-23 | |
| 2014-12-31 | $100.00K 10-K · filed 2016-02-25 | $99.80K 10-K · filed 2015-03-17 |
| 2013-12-31 | $214.90K 10-K · filed 2015-03-17 | |
| 2012-12-31 | $140.36K 10-K · filed 2014-03-14 | |
| 2011-12-31 | $106.69K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |